Federal NAICS Codes

NAICS 325411

Medicinal and Botanical Manufacturing

Explore obligations, trends, recent awards, and incumbent contractors for NAICS 325411.

NAICS 325411 federal market metrics

Total obligations
$95.6B
Total awards
2,082,535 awards
Active obligations
$34.4M
Size standard
1,000 employees

What this NAICS covers

NAICS 325411 covers producing medicinal and botanical products, including formulation, batch production, fabrication, filling, labeling, packaging, factory testing, and maintaining quality and production records for pharmaceutical and botanical preparations.

Federal opportunities under 325411 typically involve providing manufactured medicinal or botanical products that meet specification and regulatory quality controls, including batch release documentation, stability testing, packaging, lot traceability, and delivery for clinical or operational use.

FY2025 snapshot

Obligations
$4.9B
Awards
119,104
Average award
$40.8K
Change from FY2024
+5.4%

Recent awards

Search contractors

$13,240

GUMIX INTERNATIONAL, INC.

Animal and Plant Health Inspection Service

PIID
12639526P0138
PSC
6505 - DRUGS AND BIOLOGICALS

FAQ

What work fits NAICS 325411?
  • Production and batch release of botanical extracts standardized to specified marker-compound concentrations, supplied with certificates of analysis and stability data.
  • Manufacture of active pharmaceutical ingredients and intermediates with GMP batch records, traceability, and impurity profiling for research or clinical supply.
  • Contract manufacture of sterile compounded medicinal products in controlled cleanroom environments with sterility certificates and validated aseptic processes.
  • Scale-up production runs of formulation batches with validated analytical methods, stability testing, and lot-level release documentation for procurement acceptance.
When is NAICS 325411 a weak fit?
  • Pharmaceutical research and development contracts that require formulation development, non-GMP pilot studies, or early-stage clinical trial formulation research without GMP production or lot release obligations.
  • On-site clinical pharmacy compounding at point-of-care locations that prepare patient-specific doses rather than producing GMP-manufactured batches in a controlled facility.
  • Medical product distribution solicitations focused on logistics, storage, and delivery of finished medicines without manufacturing, batch testing, or GMP documentation responsibilities.
What solicitation language points to NAICS 325411?
  • Requirement for GMP certification, validated manufacturing processes, and submission of batch records and certificates of analysis with each shipment.
  • Deliverables that include sterility testing results, stability data, and full chain-of-custody for botanical raw materials and excipients.
  • Evaluation factors that prioritize vendor experience in GMP batch production, validated analytical testing, and regulatory-compliant lot release procedures.

Put this market knowledge to work

Now that you know about NAICS 325411 - Medicinal and Botanical Manufacturing, let Sweetspot help you find and win relevant government contracts with AI-powered tools.